23 Apr 2019

PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein

  VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug

0
13 Apr 2019

BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

0
13 Apr 2019

DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium

Ra Medical Systems Inc., headquartered in Carlsbad, California, has scheduled its key DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. Ra Medical is in Booth No. 509. These events include case and podium presentations and

0
10 Apr 2019

AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE

  The U.S. Federal Drug Administration granted Aninger’s Pantheris SV small vessel image-guided atherectomy system pre-market approval in eight months. The Pantheris SV is an extension of the Redwood City, California-based company’s lumivascular image-guided atherectomy platform, which it hopes will expand the available market for its Pantheris devices by up

0
10 Apr 2019

Teleflex gets premarket OK for biomechanical MANTA Closure

  Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial

0
09 Apr 2019

 MERZ NORTH AMERICA REGAINS EXCLUSIVE DISTRIBUTION OF ASCLERA (POLIDOCANOL) INJECTION

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

0
28 Mar 2019

SIGVARIS CHANGES CORPORATE NAME, LOGO

        SIGVARIS has changed its corporate name from SIGVARIS to SIGVARIS GROUP and has also changed its logo. SIGVARIS has a 150-year history of proven success, according to CEO Mark Bunker. “We are the world leader in medical compression socks and hosiery with a wide assortment of

0
06 Mar 2019

PATIENTS EXPERIMENT WITH PRESCRIPTION DRUGS TO FIGHT AGING

By Marisa Taylor Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives. Over the past two years, more than 200 patients have flocked to see Dr. Green after learning that two drugs he prescribes could possibly stave off aging.

0
18 Dec 2018

MERIT MEDICAL ACQUIRES ASSETS OF VASCULAR INSIGHTS DEC 17

  Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, announced Dec. 17 that it has acquired substantially all of the assets of Vascular Insights LLC, based in Quincy, Massachusetts. Vascular Insights’ primary assets are the ClariVein IC and ClariVein

0
08 Nov 2018

VIVA 2018: BTG SENTRY BIOCONVERTIBLE IVC FILTER STUDY SHOWS FLAWLESS PERFORMANCE

  BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the

0